Brian Daniel Webster - 06 Mar 2025 Form 3 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Role
President and Chief Executive Officer, Director
Signature
/s/ Brian Webster
Issuer symbol
KMTS
Transactions as of
06 Mar 2025
Transactions value $
$0
Form type
3
Filing time
06 Mar 2025, 21:02:45 UTC
Next filing
21 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KMTS Common Shares 309K 06 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KMTS Options 06 Mar 2025 Common Shares 1.78M $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,068,000 fully vested options and 712,000 options that will vest as follows: 356,000 of such options will vest on March 6, 2026, and the remaining 356,000 will vest monthly over the following year.

Remarks:

President and Chief Executive Officer